181 related articles for article (PubMed ID: 35100723)
21. Handling intercurrent events and missing data in non-inferiority trials using the estimand framework: A tuberculosis case study.
Rehal S; Cro S; Phillips PP; Fielding K; Carpenter JR
Clin Trials; 2023 Oct; 20(5):497-506. PubMed ID: 37277978
[TBL] [Abstract][Full Text] [Related]
22. Application of estimand framework in ICH E9 (R1) to safety evaluation.
Wang X; Yang P; Yuan SS; Wang WWB
J Biopharm Stat; 2023 Jul; 33(4):476-487. PubMed ID: 36951445
[TBL] [Abstract][Full Text] [Related]
23. Demystifying the estimand framework: a case study using patient-reported outcomes in oncology.
Fiero MH; Pe M; Weinstock C; King-Kallimanis BL; Komo S; Klepin HD; Gray SW; Bottomley A; Kluetz PG; Sridhara R
Lancet Oncol; 2020 Oct; 21(10):e488-e494. PubMed ID: 33002444
[TBL] [Abstract][Full Text] [Related]
24. Estimands for clinical endpoints in Tuberculosis treatment randomized controlled trials: a retrospective application in a completed trial.
Weir IR; Dufault SM; Phillips PP
Res Sq; 2023 Nov; ():. PubMed ID: 37986887
[TBL] [Abstract][Full Text] [Related]
25. Use of the Estimand Framework to Manage the Disruptive Effects of COVID-19 on Stroke Clinical Trials.
Yassi N; Hayward KS; Campbell BCV; Churilov L
Stroke; 2021 Nov; 52(11):3739-3747. PubMed ID: 34587797
[TBL] [Abstract][Full Text] [Related]
26. Defining Clinical Trial Estimands: A Practical Guide for Study Teams with Examples Based on a Psychiatric Disorder.
Polverejan E; O'Kelly M; Hefting N; Norton JD; Lim P; Walton MK
Ther Innov Regul Sci; 2023 Sep; 57(5):911-939. PubMed ID: 37244885
[TBL] [Abstract][Full Text] [Related]
27. The estimand framework and its application in substance use disorder clinical trials: a case study.
Roydhouse JK; Floden L; Tomko RL; Gray KM; Bell ML
Am J Drug Alcohol Abuse; 2021 Nov; 47(6):658-663. PubMed ID: 34702088
[TBL] [Abstract][Full Text] [Related]
28. Estimands in published protocols of randomised trials: urgent improvement needed.
Kahan BC; Morris TP; White IR; Carpenter J; Cro S
Trials; 2021 Oct; 22(1):686. PubMed ID: 34627347
[TBL] [Abstract][Full Text] [Related]
29. Defining estimands using a mix of strategies to handle intercurrent events in clinical trials.
Qu Y; Shurzinske L; Sethuraman S
Pharm Stat; 2021 Mar; 20(2):314-323. PubMed ID: 33098267
[TBL] [Abstract][Full Text] [Related]
30. Rethinking intercurrent events in defining estimands for tuberculosis trials.
Pham TM; Tweed CD; Carpenter JR; Kahan BC; Nunn AJ; Crook AM; Esmail H; Goodall R; Phillips PP; White IR
Clin Trials; 2022 Oct; 19(5):522-533. PubMed ID: 35850542
[TBL] [Abstract][Full Text] [Related]
31. Estimation of treatment effects in short-term depression studies. An evaluation based on the ICH E9(R1) estimands framework.
Mitroiu M; Teerenstra S; Oude Rengerink K; Pétavy F; Roes KCB
Pharm Stat; 2022 Sep; 21(5):1037-1057. PubMed ID: 35678545
[TBL] [Abstract][Full Text] [Related]
32. Defining Efficacy Estimands in Clinical Trials: Examples Illustrating ICH E9(R1) Guidelines.
Ratitch B; Goel N; Mallinckrodt C; Bell J; Bartlett JW; Molenberghs G; Singh P; Lipkovich I; O'Kelly M
Ther Innov Regul Sci; 2020 Mar; 54(2):370-384. PubMed ID: 32072586
[TBL] [Abstract][Full Text] [Related]
33. Seeking harmony: estimands and sensitivity analyses for confirmatory clinical trials.
Mehrotra DV; Hemmings RJ; Russek-Cohen E;
Clin Trials; 2016 Aug; 13(4):456-8. PubMed ID: 26908545
[TBL] [Abstract][Full Text] [Related]
34. Treatment effect quantification for time-to-event endpoints-Estimands, analysis strategies, and beyond.
Rufibach K
Pharm Stat; 2019 Mar; 18(2):145-165. PubMed ID: 30478869
[TBL] [Abstract][Full Text] [Related]
35. Application of estimand framework to the design and analysis of multi-regional clinical trials.
Niu C; Liang L; Fu R; Zhong W; Wang WWB
J Biopharm Stat; 2024 Jun; ():1-17. PubMed ID: 38840476
[TBL] [Abstract][Full Text] [Related]
36. Estimands in practice: Bridging the gap between study objectives and statistical analysis.
Phillips A; Clark T
Pharm Stat; 2021 Jan; 20(1):68-76. PubMed ID: 32893473
[TBL] [Abstract][Full Text] [Related]
37. Estimands-A Basic Element for Clinical Trials.
Pohl M; Baumann L; Behnisch R; Kirchner M; Krisam J; Sander A
Dtsch Arztebl Int; 2021 Dec; 118(51-52):883-888. PubMed ID: 34857075
[TBL] [Abstract][Full Text] [Related]
38. Connecting Instrumental Variable methods for causal inference to the Estimand Framework.
Bowden J; Bornkamp B; Glimm E; Bretz F
Stat Med; 2021 Nov; 40(25):5605-5627. PubMed ID: 34288021
[TBL] [Abstract][Full Text] [Related]
39. Hypothetical Estimands in Clinical Trials: A Unification of Causal Inference and Missing Data Methods.
Olarte Parra C; Daniel RM; Bartlett JW
Stat Biopharm Res; 2023; 15(2):421-432. PubMed ID: 37260584
[TBL] [Abstract][Full Text] [Related]
40. Estimands for factorial trials.
Kahan BC; Morris TP; Goulão B; Carpenter J
Stat Med; 2022 Sep; 41(22):4299-4310. PubMed ID: 35751568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
